[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:large-b-cell-lymphoma-with-irf4-rearrangement":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Large B-Cell Lymphoma with IRF4 Rearrangement",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06834373","Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy",[11],"Phase 2","RECRUITING","2026-08-26T02:16:14.341106Z","2026-05-05T02:43:26.687370Z",[],[]]